Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$1.92avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Travere Therapeutics Inc. (tvtx 2.25 03/01/29) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Nomura Holdings Inc. ($4.7M) and Jane Street Group, LLC ($1.8M).
- Company
- Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
- CUSIP
- 89422GAA5
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 11,483 shares bought and 500,000 shares sold, net −488,517 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Nomura Holdings Inc. | 0.03% | Add +2.0% | 575,870 | $4.7M |
| Jane Street Group, LLC | 0.00% | Reduce -15.0% | 2,833,000 | $1.8M |
"% of holder's portfolio" is TRAVERE THERAPEUTICS INC (TVTX 2.25 03/01/29)'s weight in each manager's 13F, not the share of Travere Therapeutics Inc. (tvtx 2.25 03/01/29) the manager owns.